Expert commentary on cannabis law, IP, advertising, and risk management worldwide.
A Michigan breach-of-contract dispute between cultivator Hello Farms and Curaleaf Holdings has cracked open a fault line that runs beneath every cannabis contract in the US, opening the door to a ‘mutually assured destruction’ defence that cannot be closed.
The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads.
Expanding NHS access to medical cannabis could add £13.3bn to the UK economy over 10 years, easing NHS costs and reducing long-term sickness.
Switzerland’s draft cannabis plan proposes a single online retailer, raising opportunities and risks as it pursues Europe’s first adult-use market.
The European Commission (EC) is considering a major overhaul of regulations surrounding hemp across the Union, potentially marking a step change in how hemp is recognised, traded, and funded.
The blistering growth of Germany’s medical cannabis sector showed no signs of abating through the second quarter of 2025, with imports rising another 15% to hit new records.
You can also read this story in German, here. When the Cannabis Act came into force in Germany, the aim was to improve the country’s drug policy by changing the way the popular recreational drug was handled.
Slovenia is making its own move toward legalisation, at least in part, for personal consumption. As reported two weeks ago by the Slovenian news agency Index, members of Slovenia’s governing coalition, comprising the Freedom Movement (Gibanje Svoboda) and the Left (Levica), have submitted a draft bill to parliament aimed at regulating personal cannabis use. Natasa Sukic, a member of parliament from Levica, said the goal is to implement the will of the voters.
As part of the FSA’s re-energised efforts to push forward with the long-running CBD novel foods approvals process, the agency has continued to actively liaise with industry stakeholders regarding their applications.
